{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:07:50Z","timestamp":1792804070776,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100011199","name":"CAS | State Key Laboratory of Microbial Resources","doi-asserted-by":"publisher","award":["XDB0810000"],"award-info":[{"award-number":["XDB0810000"]}],"id":[{"id":"10.13039\/501100011199","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Key Research and Development Program of Shandong Province, China"},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22374016"],"award-info":[{"award-number":["22374016"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32370090"],"award-info":[{"award-number":["32370090"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-75746-7","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:08:31Z","timestamp":1785402511000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Rapid and quantitative measurement of bacteriophage infectivity via fully automated droplet digital PCR"],"prefix":"10.1038","volume":"17","author":[{"given":"Yanfei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9993-9795","authenticated-orcid":false,"given":"Huiwei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shize","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjing","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3834-1145","authenticated-orcid":false,"given":"Zhangrun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0634-8396","authenticated-orcid":false,"given":"Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7401-1410","authenticated-orcid":false,"given":"Wenbin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"key":"75746_CR1","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","volume":"404","author":"G. B. D. 2021 Antimicrobial Resistance Collaborators","year":"2024","unstructured":"G. B. D. 2021 Antimicrobial Resistance Collaborators Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050. Lancet 404, 1199\u20131226 (2024).","journal-title":"Lancet"},{"key":"75746_CR2","doi-asserted-by":"publisher","first-page":"9557","DOI":"10.1002\/anie.201602763","volume":"55","author":"NG Schoepp","year":"2016","unstructured":"Schoepp, N. G. et al. Digital quantification of DNA replication and chromosome segregation enables the determination of antimicrobial susceptibility after only 15\u2009min of antibiotic exposure. Angew. Chem. Int. Ed. 55, 9557\u20139561 (2016).","journal-title":"Angew. Chem. Int. Ed."},{"key":"75746_CR3","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aal3693","volume":"9","author":"NG Schoepp","year":"2017","unstructured":"Schoepp, N. G. et al. Rapid pathogen-specific phenotypic antibiotic susceptibility testing using digital LAMP quantification in clinical samples. Sci. Transl. Med. 9, eaal3693 (2017).","journal-title":"Sci. Transl. Med."},{"key":"75746_CR4","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41564-019-0634-z","volume":"5","author":"A Petrovic Fabijan","year":"2020","unstructured":"Petrovic Fabijan, A. et al. Safety of bacteriophage therapy in severe Staphylococcus aureus infection. Nat. Microbiol. 5, 465\u2013472 (2020).","journal-title":"Nat. Microbiol."},{"key":"75746_CR5","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s41579-024-01054-w","volume":"22","author":"WR Miller","year":"2024","unstructured":"Miller, W. R. & Arias, C. A. ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics. Nat. Rev. Microbiol. 22, 598\u2013616 (2024).","journal-title":"Nat. Rev. Microbiol."},{"key":"75746_CR6","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adp6604","volume":"10","author":"Q Zhou","year":"2024","unstructured":"Zhou, Q. et al. Fluoroamphiphilic polymers exterminate multidrug-resistant Gram-negative ESKAPE pathogens while attenuating drug resistance. Sci. Adv. 10, eadp6604 (2024).","journal-title":"Sci. Adv."},{"key":"75746_CR7","doi-asserted-by":"publisher","first-page":"e00181","DOI":"10.1128\/CMR.00181-19","volume":"33","author":"DMP De Oliveira","year":"2020","unstructured":"De Oliveira, D. M. P. et al. Antimicrobial resistance in ESKAPE pathogens. Clin. Microbiol. Rev. 33, e00181\u201319 (2020).","journal-title":"Clin. Microbiol. Rev."},{"key":"75746_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cell.2022.11.017","volume":"186","author":"SA Strathdee","year":"2023","unstructured":"Strathdee, S. A., Hatfull, G. F., Mutalik, V. K. & Schooley, R. T. Phage therapy: From biological mechanisms to future directions. Cell 186, 17\u201331 (2023).","journal-title":"Cell"},{"key":"75746_CR9","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/s41591-019-0437-z","volume":"25","author":"RM Dedrick","year":"2019","unstructured":"Dedrick, R. M. et al. Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus. Nat. Med. 25, 730\u2013733 (2019).","journal-title":"Nat. Med."},{"key":"75746_CR10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/cid\/ciac453","volume":"76","author":"RM Dedrick","year":"2022","unstructured":"Dedrick, R. M. et al. Phage therapy of Mycobacterium infections: compassionate use of phages in 20 patients with drug-resistant mycobacterial disease. Clin. Infect. Dis. 76, 103\u2013112 (2022).","journal-title":"Clin. Infect. Dis."},{"key":"75746_CR11","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/emph\/eoy005","volume":"2018","author":"BK Chan","year":"2018","unstructured":"Chan, B. K. et al. Phage treatment of an aortic graft infected with Pseudomonas aeruginosa. Evol. Med. Public Health 2018, 60\u201366 (2018).","journal-title":"Evol. Med. Public Health"},{"key":"75746_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-64608-3","volume":"16","author":"K Moon","year":"2025","unstructured":"Moon, K. et al. Considerations and perspectives on phage therapy from the transatlantic taskforce on antimicrobial resistance. Nat. Commun. 16, 10883 (2025).","journal-title":"Nat. Commun."},{"key":"75746_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-026-68684-x","volume":"17","author":"TJR Penke","year":"2026","unstructured":"Penke, T. J. R. et al. High-throughput methods leveraging robotics and computer vision for the development of therapeutic phage cocktails. Nat. Commun. 17, 2192 (2026).","journal-title":"Nat. Commun."},{"key":"75746_CR14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12941-020-00389-5","volume":"19","author":"Z Chegini","year":"2020","unstructured":"Chegini, Z. et al. Bacteriophage therapy against Pseudomonas aeruginosa biofilms: a review. Ann. Clin. Microbiol. Antimicrob. 19, 45 (2020).","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"75746_CR15","doi-asserted-by":"publisher","first-page":"1000721","DOI":"10.3389\/fcimb.2022.1000721","volume":"12","author":"V Daubie","year":"2022","unstructured":"Daubie, V. et al. Determination of phage susceptibility as a clinical diagnostic tool: a routine perspective. Front. Cell. Infect. Microbiol. 12, 1000721 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"75746_CR16","doi-asserted-by":"publisher","first-page":"S337","DOI":"10.1093\/cid\/ciad514","volume":"77","author":"O Yerushalmy","year":"2023","unstructured":"Yerushalmy, O. et al. Towards standardization of phage susceptibility testing: the Israeli Phage Therapy Center \u201cClinical Phage Microbiology\u201d\u2014a pipeline proposal. Clin. Infect. Dis. 77, S337\u2013S351 (2023).","journal-title":"Clin. Infect. Dis."},{"key":"75746_CR17","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3390\/antibiotics14060553","volume":"14","author":"A Kline","year":"2025","unstructured":"Kline, A. et al. Current clinical laboratory challenges to widespread adoption of phage therapy in the United States. Antibiotics 14, 553 (2025).","journal-title":"Antibiotics"},{"key":"75746_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-27734-w","volume":"13","author":"JE Egido","year":"2023","unstructured":"Egido, J. E. et al. Monitoring phage-induced lysis of Gram-negatives in real time using a fluorescent DNA dye. Sci. Rep. 13, 856 (2023).","journal-title":"Sci. Rep."},{"key":"75746_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49710-2","volume":"15","author":"F Bayat","year":"2024","unstructured":"Bayat, F. et al. High-throughput platform technology for rapid target identification in personalized phage therapy. Nat. Commun. 15, 5626 (2024).","journal-title":"Nat. Commun."},{"key":"75746_CR20","doi-asserted-by":"publisher","first-page":"e2410905121","DOI":"10.1073\/pnas.2410905121","volume":"121","author":"JD Antani","year":"2024","unstructured":"Antani, J. D., Ward, T., Emonet, T. & Turner, P. E. Microscopic phage adsorption assay: High-throughput quantification of virus particle attachment to host bacterial cells. Proc. Natl. Acad. Sci. Usa. 121, e2410905121 (2024).","journal-title":"Proc. Natl. Acad. Sci. Usa."},{"key":"75746_CR21","doi-asserted-by":"publisher","first-page":"8632","DOI":"10.1021\/acs.analchem.3c01066","volume":"95","author":"X Li","year":"2023","unstructured":"Li, X. et al. Rapid bacteriophage quantification by digital biosensing on a SlipChip microfluidic device. Anal. Chem. 95, 8632\u20138639 (2023).","journal-title":"Anal. Chem."},{"key":"75746_CR22","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3390\/v10040189","volume":"10","author":"Y Xie","year":"2018","unstructured":"Xie, Y., Wahab, L. & Gill, J. J. Development and validation of a microtiter plate-based assay for determination of bacteriophage host range and virulence. Viruses 10, 189 (2018).","journal-title":"Viruses"},{"key":"75746_CR23","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1021\/acs.analchem.1c04852","volume":"94","author":"S Ye","year":"2022","unstructured":"Ye, S. et al. OsciDrop: a versatile deterministic droplet generator. Anal. Chem. 94, 2918\u20132925 (2022).","journal-title":"Anal. Chem."},{"key":"75746_CR24","doi-asserted-by":"publisher","first-page":"2309557","DOI":"10.1002\/advs.202309557","volume":"11","author":"C Li","year":"2024","unstructured":"Li, C. et al. All-in-one OsciDrop digital PCR system for automated and highly multiplexed molecular diagnostics. Adv. Sci. 11, 2309557 (2024).","journal-title":"Adv. Sci."},{"key":"75746_CR25","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1073\/pnas.55.3.614","volume":"55","author":"JS Wiberg","year":"1966","unstructured":"Wiberg, J. S. Mutants of bacteriophage T4 unable to cause breakdown of host DNA. Proc. Natl. Acad. Sci. USA 55, 614\u2013621 (1966).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"75746_CR26","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1128\/jvi.5.6.700-708.1970","volume":"5","author":"HR Warner","year":"1970","unstructured":"Warner, H. R., Snustad, D. P., Jorgensen, S. E. & Koerner, J. F. Isolation of bacteriophage T4 mutants defective in the ability to degrade host deoxyribonucleic acid. J. Virol. 5, 700\u2013708 (1970).","journal-title":"J. Virol."},{"key":"75746_CR27","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1128\/MMBR.67.1.86-156.2003","volume":"67","author":"ES Miller","year":"2003","unstructured":"Miller, E. S. et al. Bacteriophage T4 genome. Microbiol. Mol. Biol. Rev. 67, 86\u2013156 (2003).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"75746_CR28","doi-asserted-by":"publisher","unstructured":"Li, Z. et al. Nucleoid-associated proteins sense phage-induced genome damage to elicit abortive infection. Preprint at bioRxiv https:\/\/doi.org\/10.64898\/2026.04.06.716658 (2026).","DOI":"10.64898\/2026.04.06.716658"},{"key":"75746_CR29","doi-asserted-by":"publisher","unstructured":"Peng, X. et al. Metagenomic analyses of single phages and phage cocktails show instances of contamination with temperate phages and bacterial DNA. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.09.12.612727 (2024).","DOI":"10.1101\/2024.09.12.612727"},{"key":"75746_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0118557","volume":"10","author":"MK Mirzaei","year":"2015","unstructured":"Mirzaei, M. K. & Nilsson, A. Isolation of phages for phage therapy: a comparison of spot tests and efficiency of plating analyses for determination of host range and efficacy. PLOS ONE 10, e0118557 (2015).","journal-title":"PLOS ONE"},{"key":"75746_CR31","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1146\/annurev-virology-011620-040628","volume":"7","author":"A Lopatina","year":"2020","unstructured":"Lopatina, A., Tal, N. & Sorek, R. Abortive infection: bacterial suicide as an antiviral immune strategy. Annu. Rev. Virol. 7, 371\u2013384 (2020).","journal-title":"Annu. Rev. Virol."},{"key":"75746_CR32","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/j.cell.2020.09.065","volume":"183","author":"A Millman","year":"2020","unstructured":"Millman, A. et al. Bacterial retrons function in anti-phage defense. Cell 183, 1551\u20131561.e12 (2020).","journal-title":"Cell"},{"key":"75746_CR33","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1016\/j.molcel.2021.03.027","volume":"81","author":"CK Guegler","year":"2021","unstructured":"Guegler, C. K. & Laub, M. T. Shutoff of host transcription triggers a toxin-antitoxin system to cleave phage RNA and abort infection. Mol. Cell 81, 2361\u20132373.e9 (2021).","journal-title":"Mol. Cell"},{"key":"75746_CR34","doi-asserted-by":"publisher","first-page":"102293","DOI":"10.1016\/j.mib.2023.102293","volume":"73","author":"A Kelly","year":"2023","unstructured":"Kelly, A., Arrowsmith, T. J., Went, S. C. & Blower, T. R. Toxin\u2013antitoxin systems as mediators of phage defense and the implications for abortive infection. Curr. Opin. Microbiol. 73, 102293 (2023).","journal-title":"Curr. Opin. Microbiol."},{"key":"75746_CR35","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1016\/j.cell.2023.02.029","volume":"186","author":"A Stokar-Avihail","year":"2023","unstructured":"Stokar-Avihail, A. et al. Discovery of phage determinants that confer sensitivity to bacterial immune systems. Cell 186, 1863\u20131876.e16 (2023).","journal-title":"Cell"},{"key":"75746_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53614-6","volume":"15","author":"X Zhen","year":"2024","unstructured":"Zhen, X. et al. Mechanistic basis for the allosteric activation of NADase activity in the Sir2-HerA antiphage defense system. Nat. Commun. 15, 9269 (2024).","journal-title":"Nat. Commun."},{"key":"75746_CR37","doi-asserted-by":"publisher","first-page":"4586","DOI":"10.1016\/j.molcel.2023.11.007","volume":"83","author":"Z Shen","year":"2023","unstructured":"Shen, Z., Lin, Q., Yang, X.-Y., Fosuah, E. & Fu, T.-M. Assembly-mediated activation of the SIR2-HerA supramolecular complex for anti-phage defense. Mol. Cell 83, 4586\u20134599.e5 (2023).","journal-title":"Mol. Cell"},{"key":"75746_CR38","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s41586-023-06902-y","volume":"625","author":"CF Baca","year":"2024","unstructured":"Baca, C. F. et al. The CRISPR effector Cam1 mediates membrane depolarization for phage defence. Nature 625, 797\u2013804 (2024).","journal-title":"Nature"},{"key":"75746_CR39","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41589-024-01593-6","volume":"20","author":"H Yang","year":"2024","unstructured":"Yang, H. & Patel, D. J. Structures, mechanisms and applications of RNA-centric CRISPR\u2013Cas13. Nat. Chem. Biol. 20, 673\u2013688 (2024).","journal-title":"Nat. Chem. Biol."},{"key":"75746_CR40","doi-asserted-by":"publisher","DOI":"10.1126\/science.adr0393","volume":"387","author":"Y Li","year":"2025","unstructured":"Li, Y. et al. Antiviral signaling of a type III CRISPR-associated deaminase. Science 387, eadr0393 (2025).","journal-title":"Science"},{"key":"75746_CR41","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.chom.2025.02.001","volume":"33","author":"NC Keith","year":"2025","unstructured":"Keith, N. C., Snyder, R. A., Euler, C. W. & Modell, J. W. Bacteria exploit viral dormancy to establish CRISPR-Cas immunity. Cell Host Microbe 33, 330\u2013340.e6 (2025).","journal-title":"Cell Host Microbe"},{"key":"75746_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37789-y","volume":"14","author":"R Wang","year":"2023","unstructured":"Wang, R. et al. Associate toxin-antitoxin with CRISPR-Cas to kill multidrug-resistant pathogens. Nat. Commun. 14, 2078 (2023).","journal-title":"Nat. Commun."},{"key":"75746_CR43","doi-asserted-by":"publisher","first-page":"e555","DOI":"10.1016\/S2666-5247(21)00127-0","volume":"2","author":"D Gelman","year":"2021","unstructured":"Gelman, D. et al. Clinical phage microbiology: a suggested framework and recommendations for the in-vitro matching steps of phage therapy. Lancet Microbe 2, e555\u2013e563 (2021).","journal-title":"Lancet Microbe"},{"key":"75746_CR44","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.3390\/antibiotics14121187","volume":"14","author":"C Ortiz-Cartagena","year":"2025","unstructured":"Ortiz-Cartagena, C. et al. Phage therapy for bone and joint infections: towards clinical translation. Antibiotics 14, 1187 (2025).","journal-title":"Antibiotics"},{"key":"75746_CR45","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1038\/s41564-025-02063-y","volume":"10","author":"N Aframian","year":"2025","unstructured":"Aframian, N., Omer Bendori, S., Hen, T., Guler, P. & Eldar, A. Expression level of anti-phage defense systems controls a trade-off between protection range and autoimmunity. Nat. Microbiol. 10, 1954\u20131962 (2025).","journal-title":"Nat. Microbiol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75746-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75746-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75746-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:16:57Z","timestamp":1785521817000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75746-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["75746"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-75746-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8591046\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]},"assertion":[{"value":"13 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.L., W.D., Y.L. and H.Z. are named as inventors on a Chinese patent application covering the dPhaST method, with the Institute of Microbiology, Chinese Academy of Sciences as the applicant (application no. 202610164894.0). The remaining authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"7584"}}